Rebounding Stocks: Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), KiOr Inc(NASDAQ:KIOR), and Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT)

Posted by admin September 11, 2014 0 Comment 1759 views

New York, NY – 09/11/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) traded for as little as $3.82 today, a new 52 week low for the company. However, the company’s closing price reflected an eight cent boost from the figure recorded on Sept. 9th. This 2.05% increase in value places the stock at a new closing price of $3.98. The stock also gained an additional two cents during after-hours trading. Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) currently has a market capitalization of $857.36 million and 219.84 million tradeable shares.

What Does The Future Hold For Arena Pharmaceuticals? Receive A Free ARNA Analysis.

KiOR Inc(NASDAQ:KIOR) saw its value increase by 50.48% yesterday as the stock gained $0.053 to move to a new closing price of $0.158. The stock has traded within a range of $0.09 to $3.10 over the past 52 weeks. In other words, while the boost in value enjoyed by KiOr Inc(NASDAQ:KIOR) may be significant, the company remains close to rock bottom. The company had a trading volume of 5,217,325 yesterday, a figure which is substantially higher than its three month average of 782,217.

Will KiOR Inc. Climb Out Of Its Current Hole? Take A Look At Our Free KIOR Analysis.

Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT) gained six cents as the stock moved to a new closing price of $1.12. Nevertheless, the stock, like KiOr and Arena Pharmaceuticals, remains close to its 52 week low of $0.30. To contrast, the stock is currently $4.91 below its 52 week high of $6.03. Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT), a company with a market capitalization of $187.24 million, currently has a bid price of $1.12 x 800 and an offer price of $1.15 x 5,000.

Can Provectus Biopharmaceuticals Continue To Rise? Click Here For A Free PVCT Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment